Tivic Health Systems, Inc. financial data

Symbol
TIVC on Nasdaq
Location
Fremont, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 384% % -11%
Quick Ratio 37% % -57%
Debt-to-equity 17% % -45%
Return On Equity -202% % -0.44%
Return On Assets -173% % -12%
Operating Margin -1375% % -127%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,765,952 shares -79%
Common Stock, Shares, Outstanding 1,662,921 shares -73%
Common Stock, Value, Issued $2,000 USD 100%
Weighted Average Number of Shares Outstanding, Basic 1,320,778 shares 263%
Weighted Average Number of Shares Outstanding, Diluted 881,294 shares 274%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $462,000 USD -58%
Revenue from Contract with Customer, Excluding Assessed Tax $146,000 USD 16%
Cost of Revenue $553,000 USD -31%
Research and Development Expense $2,181,000 USD 63%
Selling and Marketing Expense $1,261,000 USD -25%
General and Administrative Expense $3,684,000 USD 1%
Operating Income (Loss) $7,406,000 USD -15%
Nonoperating Income (Expense) $113,000 USD
Net Income (Loss) Attributable to Parent $7,506,000 USD -17%
Earnings Per Share, Basic 0 USD/shares 50%
Earnings Per Share, Diluted -1 USD/shares 99%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,450,000 USD 58%
Accounts Receivable, after Allowance for Credit Loss, Current $19,000 USD 111%
Inventory, Net $4,000 USD -99%
Other Assets, Current $74,000 USD
Assets, Current $3,740,000 USD 18%
Property, Plant and Equipment, Net $12,000 USD -90%
Operating Lease, Right-of-Use Asset $304,000 USD -37%
Intangible Assets, Net (Excluding Goodwill) $2,243,000 USD
Other Assets, Noncurrent $23,000 USD
Assets $6,229,000 USD 84%
Accounts Payable, Current $465,000 USD 40%
Employee-related Liabilities, Current $40,000 USD
Liabilities, Current $638,000 USD 14%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $638,000 USD 14%
Retained Earnings (Accumulated Deficit) $49,617,000 USD -18%
Stockholders' Equity Attributable to Parent $5,591,000 USD 97%
Liabilities and Equity $6,229,000 USD 84%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $889,000 USD 47%
Net Cash Provided by (Used in) Financing Activities $82,000 USD
Net Cash Provided by (Used in) Investing Activities $526,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 1,662,921 shares -73%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,333,000 USD 23%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,184,000 USD -68%
Deferred Tax Assets, Valuation Allowance $8,515,000 USD 12%
Deferred Tax Assets, Gross $8,515,000 USD 11%
Operating Lease, Liability $321,000 USD -36%
Depreciation $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid $335,000 USD -38%
Property, Plant and Equipment, Gross $24,000 USD -85%
Operating Lease, Liability, Current $180,000 USD -1.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $178,000 USD -15%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14,000 USD -63%
Deferred Tax Assets, Operating Loss Carryforwards $7,627,000 USD 13%
Preferred Stock, Shares Issued 3,984 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $108,000 USD 10%
Operating Lease, Payments $87,000 USD -58%
Additional Paid in Capital $55,206,000 USD 23%
Preferred Stock, Shares Outstanding 3,984 shares
Depreciation, Depletion and Amortization $3,000 USD -40%
Deferred Tax Assets, Net of Valuation Allowance $0 USD -100%
Share-based Payment Arrangement, Expense $478,000 USD 113%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%